29 mar 2018 · 3 Annual Report Requirements and Program Results Summary Appendix 3a: HPSA Ontario Pharmacy Spring 2017 Press Release for medical sharps that are sold for use in the province of Ontario but limited to the Roche Diabetes Care, a division of Hoffmann-La Rexall Dell Pharmacy #8212
| Previous PDF | Next PDF |
[PDF] Sunset Park Student Handbook
2017-2018 Sunset Park Attendance (NHCS Policy #8212) The New Medical and dental appointments should be scheduled Parental Request for an Individual Diabetes Care Plan standards provides a school climate conducive to
[PDF] Analysis of Paper-Based Colorimetric Assays With a Smartphone
at Urbana–Champaign and the College of Medicine, University of Illinois at analyzed by visual comparison against a set of color standards, to roughly estimate the of low levels can aid in early detection and management of diabetic ketoacido- 3M, #8212), and polycarbonate film to allow samples to inter- face with the
[PDF] Annual Report - Health Products Stewardship Association
29 mar 2018 · 3 Annual Report Requirements and Program Results Summary Appendix 3a: HPSA Ontario Pharmacy Spring 2017 Press Release for medical sharps that are sold for use in the province of Ontario but limited to the Roche Diabetes Care, a division of Hoffmann-La Rexall Dell Pharmacy #8212
[PDF] Code No 5001 Second Year – March 2017 - DHSE Kerala
郡拊咎册 驳“げ ‰ #8212;Σ‰ò 巫Ч Б唬 '景 Ÿ￥抹稗‰ 挨G氮幔 #8212; ‰叭惨˜ ‰ #8220;熬 œ ］ ‚ 荒喽警ƒ 氮峁„愣く‹熬 爿 开黏哀 ˜
Artificial Intelligence XXXIV
12 déc 2017 · presented at AI-2017, the 37th SGAI International Conference on University Medicine of Rostock, Germany Predicting Service Levels Using Neural Networks (i) Q&A from Stack Exchange (ii) Prima Indian Diabetes (iii) Credit M J : Application of big-data in healthcare analytics #8212; Prospects
[PDF] BOE Policy Manual - East Syracuse Minoa
Standards of GAGAS are organized as general, fieldwork, and reporting a) Performs professional medical services in the examination and care of school children; NOTE: Refer also to Policy #8212 -- Safe Driving Program Education Law Sections 1804(4), 1906(1), 2002(1), 2017(5), 2017(6), 2022(1), 2023-a and
[PDF] Return of Organization Exempt From Income Tax - Foundationcenter
30 jui 2007 · See the instructions for exceptions and filing requirements for Form TD F 90-22 1, Report of Foreign Bank Form 990 A hospital or a cooperative hospital service organization and diabetes prevention to children and parents 2017 Mission Street, 93030 10 000 for Pipeline Program, account #8212
[PDF] New Mexico Training Range Initiative - B-21 Raider Bomber Basing
Baseline Aircraft Noise Levels Under Existing and Proposed Airspace “3-18 Sumner, and Plains Regional Medical Center, 60 miles east in Clovis 2017 1/27/2005 GE-1 Russell Sharon 2027 1/28/2005 GE-1 Scurlock Dan 0008 贩：穙 #65306; #8212; — rinking/householduse •Diabetes 2 3
[PDF] MTPS BOE Exhibits 1-15-2019 - Moorestown Township Public
15 jan 2019 · Maintaining a Loss Ratio Below 50 for 2017-2018 Medical Examination Prior to Participation on School Wendy Walker, as a Child Caregiver for the Extended Day Care Program for Republic Bank #8212 Content Standards and the requirements of the Board of Education for promotion to the
[PDF] West Ada School District 2017-2018 Traditional Student Calendar
[PDF] STANDARDS OF MEDICAL CARE IN DIABETES #8212 2017
[PDF] CODE DE COMMERCE
[PDF] La Main invisible d-Adam Smithpdf - Université Paris 1 Panthéon
[PDF] Adam Smith : richesse des nations / Courcelle-Seneuil - Gallica - BnF
[PDF] Adam Smith : richesse des nations / Courcelle-Seneuil - Gallica - BnF
[PDF] adaptation ? la situation d 'écriture cohérence du texte utilisation d 'un
[PDF] L 'adaptation littéraire au cinéma - CIEP
[PDF] Les adaptations physiques et comportementales
[PDF] Adaptation des êtres vivants aux conditions du milieu
[PDF] L 'adaptation des êtres vivants ? leur milieu
[PDF] L 'ADAPTATION Les animaux qui restent #8230
[PDF] sciences - Milan écoles
[PDF] Action des facteurs climatiques sur les animaux - SVT Ghediri
Annual Report
on theOntario Medications Return Program
and theOntario Sharps Collection Program
for the period ofJanuary 1, 2017 - December 31, 2017
Submitted
to:Wendy Ren, Ph.D
Director
Resource Recovery Policy Branch
Climate Change and Environmental Policy Division
Ministry of the Environment and Climate Change
Prepared
by:Ginette Vanasse
Director
General,
330-2255 St. Laurent Blvd.
Ottawa, ON K1G 4K3
March29, 2018
2017 Annual Report Page 1
Contents
Definitions ..................................................................................................................................................... 2
1 Executive Summary ............................................................................................................................... 3
Figure 1: Number of Collection Sites/Stewards Over the Last 5 Years ..................................................... 3
Figure 2: Program Performance - 2013-2017 OMRP Results.................................................................... 4
Figure 3: Program Performance - 2013-2017 OMRP Results.................................................................... 4
2 Program Overview ................................................................................................................................ 5
2.1 Collection Sites ............................................................................................................................ 5
3 Annual Report Requirements and Program Results Summary ............................................................. 6
4 Collection System ................................................................................................................................ 12
4.1 Program Performance ............................................................................................................... 12
Table 1: Summary of Medications and Sharps Waste Collected by Quarter in 2017 ......................... 12
4.2 Ontario Medications Return Program ....................................................................................... 12
Table 2: Program Performance - Medications Report by Quarter in 2017 ........................................ 13
4.3 Ontario Sharps Collection Program ........................................................................................... 13
Table 3: Program Performance - Sharps Report by Quarter in 2017 .................................................. 15
5 Promotion and Education Strategy ..................................................................................................... 16
5.1 Regulatory Requirements for Promotion and Education .......................................................... 16
5.2 Retail Pharmacy ......................................................................................................................... 16
5.3 HPSA Website ............................................................................................................................ 18
5.4 HPSA Producer Members' Website ........................................................................................... 18
5.5 Pharmacy Participation ............................................................................................................. 18
5.6 Municipalities ............................................................................................................................ 19
Table 4: Program Promotion in Municipal Calendars ......................................................................... 20
Appendix 1 a): HPSA Producer Members - OMRP ................................................................................. 22
Appendix 1 b): HPSA Producer Members - OSCP ................................................................................... 24
Appendix 2: Auditor's Report (Opinion from a Licensed Public Accountant) ......................................... 25
Appendix 3a: HPSA Ontario Pharmacy Spring 2017 Press Release ........................................................ 28
Appendix 3b: HPSA Ontario Pharmacy Spring 2017 Press Release ........................................................ 29
Appendix 4: List of Registered Pharmacies with OMRP & OSCP December 31, 2017 ............................ 32
Appendix 5: Producer Member Websites ............................................................................................... 58
2017 Annual Report Page 2
Definitions
The following terminology is used throughout this document: Collection Sites: Community pharmacies who are registered in the program to collect unused and expired health products from the public. Consumer Health Products: Health Canada defines consumer health products as products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner, and consumers can safely select and use these products to maintain and improve their health. Health Products: Prescription drugs, non-prescription drugs, and natural health products. Member: Brand-owner/steward/producer who is a member of HealthProducts Stewardship Association (HPSA).
Natural Health Products: Vitamins and minerals, herbal remedies, homeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, and other products like amino acids and essential fatty acids.OMRP: Ontario Medications Return Program
OSCP: Ontario Sharps Collection Program
Pharmaceuticals: Subject to subsection (2), a drug within the meaning of section 2 of the Food and Drugs Act (Canada) that is sold to consumers in Ontario, whether it is sold by the producer of the pharmaceutical or by another person; and includes a natural health product within the meaning of the NaturalHealth Products Regulations made under that Act.
Regulation: Environmental Protection Act 298/12
Producer: Means a person who manufactures or processes a pharmaceutical or sharp for the purpose of sale.2017 Annual Report Page 3
1 Executive Summary
Since 2013, the Health Products Stewardship Association (HPSA) has administered the Ontario Medications Return Program (OMRP) for prescriptions drugs, non-prescription drugs and natural health products as well as the Ontario Sharps Collection Program (OSCP) for medical sharps that are sold for use in the province of Ontario but limited to the "consumer/residential" waste stream. These programs are operated under the principles defined by Ontario Regulation 298/12 "Collection of Pharmaceuticals and Sharps - Responsibilities of Producers" and which is Ontario's first Extended Producer Responsibility regulation created under theEnvironmental Protection Act (EPA).
These programs were developed from past successes of HPSA's disposal systems in British Columbia, Manitoba and Prince Edward Island on behalf of its producer members selling prescription drugs, non-prescription drugs, natural health products and medical sharps. The OMRP and OSCP were designed to ensure that collection sites are available to all regions of the province, and that health products returned by the public are packaged, handled, transported, and disposed of in a safe, compliant and environmentally responsible manner. Figure 1 shows the participation rate of community pharmacies licensed by the Ontario College of Pharmacists as well as the number of stewards (161) supporting these programs in 2017. Participation of pharmacies has remained above 90% as required under the EPAReg 298/12.
Figure
1: Number of Collection Sites/Stewards Over the Last 5 Years
020406080100120140160180
30003100320033003400350036003700380039004000
20132014201520162017
Participation
Collection SitesStewards
Number
ofCollection
SitesNumber
ofStewards
2017 Annual Report Page 4
Figure 2 is a summary of the OMRP performance over the past five years. Since 2016 the net weight of health product waste sent for destruction has been reported, rather than the gross weight collected through pharmacies.Figure
2: Program Performance - 2013-2017 OMRP Results
Figure 3 is a summary of the OSCP performance over the past five years. A steady increase year-over-year has been demonstrated.Figure
3: Program Performance - 2013-2017 OMRP Results
20132014201520162017
Weight (Kg)
OMRP Results
20132014201520162017
Weight (Kg)
OSCP Results
2017 Annual Report Page 5
2 Program Overview
2.1 Collection Sites
HPSA acted collectively on behalf of its producer members, allowing industry to meet the regulatory requirement of more than 90% of accredited retail pharmacies being registered in OMRP and OSCP by January 1, 2017. The eligible number of accredited pharmacies in Ontario was4,284 as posted by the Director on the Ministry of the Environment and Climate Change (MOECC)
website as of October 1, 2017. HPSA's collection network was comprised of 3,929 pharmacy collection sites on December 31,2017, or approximately 91.7% of eligible pharmacies in Ontario. HPSA's collection site network
increased over the course of 2017. HPSA continues to develop new guidelines and to reach out to newly registered pharmacies. Guidelines can be found on the HPSA website by visiting:2017 Annual Report Page 6
3 Annual Report Requirements and Program Results Summary
Regulation 298/12, Section 9 "Annual Report"
Section 9 (2) A report required under subsection (1) may be prepared on behalf of more than one producer
of pharmaceuticals or sharps and, if this is done, the report shall set out, at a minimum, the following
information with respect to those producers:Section 9 (2) 1 - Requirement:
The name of each producer on whose behalf the report is prepared.Section 9 (2) 1 - Result:
The list of producer members (human and animal health) for pharmaceuticals (health products) is attached in Appendix 1 a).The list of producer members (human and animal health) for sharp devices is attached in Appendix 1 b).
Section 9 (2) 2 Item #1 - Requirement:
The number of collection locations and the location of each of the collection locations at which collection
of the designated material of the producers was provided for by all of the producers...The regulation requires producers to have 90 per cent of retail locations in Ontario, as of October 1.
Section 9 (2) 2 Item #1 - Result
x As of December 31, 2017, 91.7% of eligible pharmacy collection locations in Ontario were registered with
HPSA or 3,929.
Section 9 (2) 2 Item #2 - Requirement:
... a description of any changes that occurred with respect to the number and location of collection locations
from the previous calendar year.Section 9 (2) 2 Item #2 - Result:
HPSA's collection network for the OMRP and OSCP as reported in 2016 was 3,752. A net increase of 177
for a total of 3,929, the end of 2017 sites was a result of outreach to newly accredited pharmacies across
Ontario.
Section 9 (2) 3 - Requirement:
The information mentioned in paragraphs 2 to 7 of subsection (1), reported with respect to all of the producers
as a group.Section 9 (1) 2 - Requirement:
The total weight of all of the following that was collected at the collection locations during the previous
calendar year: i. Pharmaceuticals. ii. Containers described in paragraph 3 of section 2, excluding any containers that were recycled.Section 9 (1) 2 - Result:
In 2017, a total of 291,273.39 kilograms of pharmaceutical waste was destroyed by incineration. This number includes the weight of containers in which consumers may have brought the pharmaceuticals to the collection locations.Section 4.2 of this report provides a summary by district of the total weight of pharmaceuticals returned
and disposed of.2017 Annual Report Page 7
Section 9 (1) 3 - Requirement:
The total weight of all of the following that was collected at the collection locations during the previous
calendar year: i. Sharps. ii. Containers described in paragraph 3 of subsection 3 (1).Section 9 (1) 3 - Result:
In 2017, a total of 292,153.96 kilograms of sharps waste was collected. The total collected includes the weight of sharps containers in which consumers brought the medical sharp devices to the collection locations.Section 4.3 of this report provides a summary by district of the total weight of sharp devices collected.
Section 9 (1) 4 - Requirement:
A description of how the designated material of the producer collected at collection locations was handled and
how it was disposed of during the previous calendar year.Section 9 (1) 4 - Result:
Pharmaceuticals collected in the OMRP are packaged in lined, reusable, 23L/60L pharmaceutical wastepails/tubs at the collection locations. When ready for shipment, collection locations tie off the pail liner,
secure the lid to the base and arrange for shipment. Stericycle, ULC or ECS Cares transports the waste to
the HPSA approved Stericycle disposal site where the pharmaceuticals and any associated packaging are
incinerated. See Section 5.2 for more detail.Biomedical sharps collected in the OSCP are received from consumers in sharps containers labelled with
a Biohazard symbol. At the collection location these sharps containers are packaged in lined, corrugated
cardboard waste boxes. When ready for shipment, collection locations tie off the box liner, seal the box
and arrange for shipment. Stericycle, ULC and ECS Cares transports the boxes of biomedical sharps to the
HPSA approved disposal site where the boxes of biomedical sharps/sharps containers are autoclaved.See Section 5.3 for more detail.
Cytotoxic sharps collected in the OSCP are received from consumers in sharps containers labelled with a
cytotoxic symbol. At the collection location these sharps containers are packaged in lined, corrugatedcardboard, boxes with cytotoxic labelling on the outside. When ready for shipment, collection locations
tie off the box liner, seal the box and arrange for shipment. Stericycle, ULC. and ECS Cares transports the
boxes of cytotoxic sharps to the HPSA approved disposal site where the boxes of cytotoxic sharps and sharps containers are incinerated. See section 5.3 for more detail.2017 Annual Report Page 8
Section 9 (1) 5 - Requirement:
A description of actions taken by the producer during the previous calendar year, their effectiveness and outcomes
achieved as part of complying with sections 2, 3, 4 and 7.